0 TSX Venture News - September 22, 2020Cartier presents the strong hoisting capabilities of the shaft on the Chimo Mine PropertyHighlights:With simple adjustments, the shaft on the Chimo Mine Property could extract 1.7 million metric tons per year (4,921 mt/day).This […]Read More
0 NYSE Companies - September 22, 2020DTE Energy Company Announces Junior Subordinated Debentures OfferingDetroit, Sept. 22, 2020 (GLOBE NEWSWIRE) — DETROIT, Sept. 22, 2020 — DTE Energy Company (NYSE: DTE) announced today its […]Read More
0 NASDAQ Companies - September 22, 2020Vislink Technologies Retains KCSA Strategic Communications as Corporate Communications CounselHACKETTSTOWN, NJ, Sept. 22, 2020 (GLOBE NEWSWIRE) — Vislink Technologies, Inc. (“Vislink” or the “Company”) (Nasdaq: VISL), the global technology […]Read More
0 TSX Venture News - September 22, 2020Aequus Announces Expansion of Medicom Partnership and Filing with Health Canada for Additional Evolve Dry Eye ProductVANCOUVER, British Columbia, Sept. 22, 2020 (GLOBE NEWSWIRE) — Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), […]Read More
0 NYSE Companies - September 22, 2020DTE Energy and Consumers Energy pledge to help build extensive Midwest electric vehicle charging networkDETROIT and JACKSON, Mich., Sept. 22, 2020 (GLOBE NEWSWIRE) — DTE Energy and Consumers Energy have announced they are joining […]Read More
0 NYSE Companies - September 22, 2020TRULICITY® (dulaglutide) est indiqué comme traitement d’appoint à un régime alimentaire, à l’exercice et au traitement standard pour réduire le risque d’accident vasculaire cérébral non mortel chez les adultes atteints de diabète de type 2 qui présentent des facteurs de risque cardiovasculaires multiples ou une maladie cardiovasculaire établieTORONTO, 22 sept. 2020 (GLOBE NEWSWIRE) — Le 11 septembre 2020, Santé Canada a approuvé l’utilisation de Trulicity® (dulaglutide) pour la réduction du […]Read More
0 NYSE Companies - September 22, 2020Trulicity® (dulaglutide) is now indicated as an adjunct to diet, exercise, and standard of care therapy to reduce the risk of non-fatal stroke in adults with type 2 diabetes mellitus who have multiple cardiovascular risk factors or established cardiovascular diseaseTORONTO, Sept. 22, 2020 (GLOBE NEWSWIRE) — On September 11, 2020, Health Canada approved Trulicity® (dulaglutide) to reduce the risk […]Read More
0 TSX News - September 22, 2020Nuvei Corporation Announces Closing of US$833 Million Initial Public Offering and Concurrent Private PlacementMONTREAL, Sept. 22, 2020 (GLOBE NEWSWIRE) — Nuvei Corporation (“Nuvei” or the “Company”) (TSX: NVEI and NVEI.U) announced today the […]Read More
0 NASDAQ Companies - September 22, 2020Genius Brands International Announces Marc Rosenberg as President of Global Brands and Chief Marketing OfficerBEVERLY HILLS, Calif., Sept. 22, 2020 (GLOBE NEWSWIRE) — Genius Brands International, Inc. (“Genius Brands” or the “Company”) (Nasdaq: GNUS), a […]Read More
0 NASDAQ Companies - September 22, 2020EMCORE Introduces New LiDAR and Optical Sensing ProductsALHAMBRA, Calif., Sept. 22, 2020 (GLOBE NEWSWIRE) — EMCORE Corporation (NASDAQ: EMKR), a leading provider of advanced mixed-signal products that […]Read More